According to 4D Molecular Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.28. In 2022 the company made an earnings per share (EPS) of -$3.32 a decrease over its 2021 EPS that were of -$2.56.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.28 | -1.2% |
2022 | -$3.32 | 29.69% |
2021 | -$2.56 | -15.82% |
2020 | -$3.04 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | -33.54% | ๐บ๐ธ USA |